Case Report: Hypercalcemia With Inappropriate 1,25-Dihydroxyvitamin D in Wegener’s Granulomatosis

This publication has 25 references indexed in Scilit:

• Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1–34) infusion test: An improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism
  Calcified Tissue International, 1990
• The Role of the Vitamin D Endocrine System in Health and Disease
  New England Journal of Medicine, 1989
• Regulation of 1,25 (OH)2D synthesis in hypoparathyroidism and pseudohypoparathyroidism
  American Journal of Physiology-Endocrinology and Metabolism, 1988
• Parathyroid hormone-independent regulation of 1,25(OH)2D in response to inhibition of bone resorption
  American Journal of Physiology-Endocrinology and Metabolism, 1988
• Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans.
  Journal of Clinical Investigation, 1986
• Serum Protein Binding of 1,25-Dihydroxyvitamin D: A Reevaluation by Direct Measurement of Free Metabolite Levels*
  Journal of Clinical Endocrinology & Metabolism, 1985
• Hypercalcemia and Elevated 1,25-Dihydroxyvitamin D Levels in a Patient with End-Stage Renal Disease and Active Tuberculosis
  New England Journal of Medicine, 1984
• Hypercalcemia in disseminated candidiasis
  The American Journal of Medicine, 1983
• Hypercalcemia in an Anephric Patient with Sarcoidosis: Evidence for Extrarenal Generation of 1,25-Dihydroxyvitamin D
  New England Journal of Medicine, 1981
• Affinity chromatography with 25-hydroxycholecalciferol ester in the isolation of the binding protein for vitamin D and its metabolites from human serum
  Metabolic Bone Disease and Related Research, 1981